Hospira Halts Shipment Of Two Drugs After FDA Warning Letter
This article was originally published in The Pink Sheet Daily
Executive Summary
Voluntary hold on Propofol, Liposyn will negatively impact 2010 sales, though acquisition of Orchid will help make up the difference.